Abstract
Objectives
Cervical cancer remains a common public health problem, despite its reduced morbidity and mortality. Exploring diverse prevention and treatment methods is essential. The aim of this meta-analysis was to evaluate the association between folic acid intake and status and the risk of cervical cancer, and discuss the feasibility of folic acid supplement.
Methods
We identified 369 articles via Ovid MEDLINE, Embase, PubMed, Springer, up to January 2019. Inclusion criteria were case-control study or RCT; folate intake or level was determined; outcomes included CIN and/or cervical cancer; correlations between folate and CIN/cervical cancer were studied; original data were obtained or calculated. We also performed these analyses within groups of studies defined by the following design characteristics: disease outcome (cervical intraepithelial neoplasia CIN, cervical cancer CC), samples resource (serum, plasma, red blood cell, diet record), location (European and American countries, Asian countries). All statistical calculations were performed using R Project software.
Results
Twenty-two case-control studies and four RCTs were included in the meta- analysis. From 22 case-control studies, there was a strong correlation between folate deficiency and risk of CIN or cancer (OR = 1.46, 95% CI [1.30, 1.63]). The overall analysis results were significantly heterogeneous (I2 = 49%, P < 0.01). The location is the main source of heterogeneity. For Asian regions, folate deficiency is a risk factor for CIN and CC (OR = 1.98, 95% CI [1.47, 2.66]; OR = 2.07, 95% CI [1.43, 3.76], respectively); however, for European and American regions, folate deficiency is only associated with CIN, OR = 1.16, 95% CI [1.01, 1.34]. From 4 RCT studies, the results showed that there was no significant correlation between folic acid supplementation and CIN outcome, RR = 1.17, 95% CI [0.90, 1.51].
Conclusions
The overall study showed that folate deficiency significantly increased the risk of CIN and cervical cancer. However, the meta-analysis of 4 RCTs did not show the benefit of folic acid supplementation for CIN regression, probably due to the lack of RCTs, large time span, different folic acid supplementation doses, and different judging criteria of CIN. Further research is needed.
Funding Sources
N/A.